Unknown NA INTERVENTIONAL 1-arm NCT05170555

Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617

Sponsor: Peking Union Medical College Hospital

Interventions 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617 68Ga-PSMA

Updated 4 times since 2022 Last updated: Dec 24, 2021 Started: Dec 1, 2021 Primary completion: Oct 1, 2022 Completion: Jul 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Renal Cell Carcinoma, this trial is ongoing. The trial is conducted by Peking Union Medical College Hospital and has accumulated 4 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2022 — Jan 2024 [monthly]

Recruiting NA

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China